 |
|
EndoMatrix was created to develop a novel approach towards tissue bulking in
incontinence and GI Reflux, and was acquired by C.R. Bard, Inc. in 1997. |
|
TransVascular, Inc. was created to develop several novel revascularization technologies
including percutaneous coronary and peripheral bypass and cell injection technologies
for cardiac regeneration, and was acquired by Medtronic, Inc. in 2003. |
| |
|
Acclarent, Inc., a company focused on developing several new technologies in
the field of ENT, exited the incubator in January 2005. |
NeoTract, Inc., ExploraMed’s second spinout, exited ExploraMed II
in
February 2006. |
Vibrynt, Inc., ExploraMed's most recent spinout, completed series A April 30, 2007.
|
|
| |
|
|
|
HOME | ABOUT
US | EXPLORAMED COMPANIES